Leishmaniasis and other dermatozoonoses in Brazil (Q34612457)

3 August 2017

1 reference

title

Leishmaniasis and other dermatozoonoses in Brazil (English)

1 reference

3 August 2017

0 references

1

Marcia Ramos-E-Silva

1 reference

3 August 2017

Claudio De Moura Castro Jacques

series ordinal

2

1 reference

3 August 2017

1 March 2002

1 reference

3 August 2017

Clinics in Dermatology

1 reference

3 August 2017

20

1 reference

3 August 2017

2

1 reference

3 August 2017

122-134

1 reference

Clinical spectrum of Leishmaniasis

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

Leishmaniasis. Public health aspects and control

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

1 reference

7 January 2021

Leishmania braziliensis braziliensis infection of the nipple.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

The life-cycle of Leishmania in the sandfly with special reference to the form infective to the vertebrate host

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

Salivary gland lysates from the sand fly Lutzomyia longipalpis enhance Leishmania infectivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

Treatment of cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

Successful treatment of antimony-resistant visceral leishmaniasis with liposomal amphotericin B in patients infected with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

Mucosal leishmaniasis unresponsive to glucantime therapy successfully treated with AmBisome

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

Cutaneous larva migrans in travelers: a prospective study, with assessment of therapy with ivermectin

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

Treatment of cutaneous larva migrans

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

Treatment of cutaneous larva migrans with albendazole. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

Treatment of larva migrans cutanea (creeping eruption): a comparison between albendazole and traditional therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

Oral myiasis: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

Orbital myiasis: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0738-081X%2801%2900251-6

7 January 2021

10.1016/S0738-081X(01)00251-6

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

11973046